Sanuwave Health Inc. (SNWV)
NASDAQ (NMS) NASDAQ (NMS) Primary 
SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript
SANUWAVE Health, Inc. ( SNWV ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Morgan Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Ian Cassel - Intelligent Fanatics Capital Management Llc Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Alex Silverman - AWM Investment Company Inc Andrew Rem Presentation Operator Good day, everyone, and welcome to the SANUWAVE earnings call. [Operator Instructions] Please note, this call may be recorded.
Sanuwave Health Inc. (SNWV) to Report Q3 Results: Wall Street Expects Earnings Growth
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q3 2025 Earnings Call October 6, 2025 5:30 PM EDT Company Participants Morgan Frank - CEO & Chairman Conference Call Participants Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Presentation Operator Good day, everyone, and welcome to the SANUWAVE Q3 Revenue Update. [Operator Instructions] Please note today's call will be recorded.
SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Morgan C. Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Albert Hanser - Unidentified Company Christopher Michael Plahm - Tall Pines Capital, LLC Kyle Royal Bauser - ROTH Capital Partners, LLC, Research Division Operator Good day, everyone, and welcome to the SANUWAVE Q2 Earnings Call.
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
Sanuwave's UltraMIST offers superior wound care, reducing costs and healing time for hospitals, making it attractive to both providers and insurers. Under new CEO Morgan Frank, Sanuwave has revitalized growth, improved margins, and uplisted to Nasdaq, with the stock price quadrupling since his appointment. Revenue growth is robust, recurring consumables sales strengthen the business model, and the company is on track to triple manufacturing capacity.
SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and CEO Peter Sorensen - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets Albert Hanser - Kestrel Christopher Davis - Founding Asset Management Ian Cassel - IFCM Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen-only mode.
SANUWAVE Health, Inc. (SNWV) Q4 2024 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q4 2024 Results Conference Call March 21, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and Chief Executive Officer Peter Sorensen - Chief Financial Officer Conference Call Participants Chris Plahm - Tall Pines Capital Carl Byrnes - Northland Capital Markets Ian Cassel - IFCM Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen-only mode.
SANUWAVE Health Inc. (SNWV) Q2 2024 Earnings Call Transcript
SANUWAVE Health Inc. (OTCQB:SNWV) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Morgan Frank - Chairman and Chief Executive Officer Peter Sorensen - Chief Financial Officer Conference Call Participants Adam Gazzola - Private Investor Operator Good day, everyone, and welcome to SANUWAVE announces highest quarterly revenue in company history Q2 2024 results. At this time, all participants are in a listen-only mode.
